The Food and Drug Administration has instructed Bayer to update the drug labeling for Yaz and other similar birth control pills to reflect recent information indicating that women that used the medications had a higher risk of developing blood clots than women that used birth control pills that had been on the market longer. The FDA’s expert panel voted 21-5 to declare the labeling for the birth...